These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 37800266)
1. Neuroleptic Malignant Syndrome with Underlying Catatonia - a Case Report. Gilson C; Jacques D; Dubois T Psychiatr Danub; 2023 Oct; 35(Suppl 2):412-414. PubMed ID: 37800266 [No Abstract] [Full Text] [Related]
2. Partially Treated Catatonia and Incipient Neuroleptic Malignant Syndrome: A Challenging Presentation. Mahgoub Y; Uy R; Hartman J Prim Care Companion CNS Disord; 2020 Oct; 22(5):. PubMed ID: 33031648 [No Abstract] [Full Text] [Related]
3. [Lethal catatonia and its differential diagnosis with the neuroleptic malignant syndrome]. Andreu Giménez L; Robert Gates J; Jover Díaz F; Pagán Acosta G; Merino Sánchez J Rev Neurol; 2002 Feb 16-28; 34(4):399-400. PubMed ID: 12022063 [No Abstract] [Full Text] [Related]
4. Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia. Komatsu T; Nomura T; Takami H; Sakamoto S; Mizuno K; Sekii H; Hatta K; Sugita M Intern Med; 2016; 55(19):2893-2897. PubMed ID: 27725556 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for neuroleptic malignant syndrome. Francis A; Chandragiri S; Petrides G Am J Psychiatry; 1998 Nov; 155(11):1639-40. PubMed ID: 9812151 [No Abstract] [Full Text] [Related]
6. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine. Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089 [TBL] [Abstract][Full Text] [Related]
7. A case of nonneuroleptic malignant syndrome. Cohen S; Fligner CL; Raisys VA; Luthi R; Dunner DL J Clin Psychiatry; 1987 Jul; 48(7):287-8. PubMed ID: 2885311 [TBL] [Abstract][Full Text] [Related]
8. [Catatonia and neuroleptic malignant syndrome in view of a psychopathological and pathophysiological overlap: a brief review]. Asztalos Z; Egervári L; Andrássy G; Faludi G; Frecska E Neuropsychopharmacol Hung; 2014 Mar; 16(1):19-28. PubMed ID: 24687015 [TBL] [Abstract][Full Text] [Related]
9. Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome. Am J Psychiatry; 1989 Sep; 146(9):1240-2. PubMed ID: 2569842 [No Abstract] [Full Text] [Related]
10. Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome. Lee JW J Clin Psychopharmacol; 2010 Feb; 30(1):3-10. PubMed ID: 20075641 [TBL] [Abstract][Full Text] [Related]
11. Neuroleptic malignant syndrome: a subtype of lethal catatonia? Ahuja N; Nehru R Acta Psychiatr Scand; 1990 Nov; 82(5):398. PubMed ID: 1980785 [No Abstract] [Full Text] [Related]
12. Neuroleptic-induced catatonia: neuroleptic malignant syndrome? de Leon J; Saiz-Ruiz J; Alonso-Abolafia A; Pico-Soler E; Munoz-Ruata J; de la Serna I Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):129-36. PubMed ID: 1967846 [TBL] [Abstract][Full Text] [Related]
13. Neuroleptic malignant syndrome and catatonia: one entity or two? Fink M Biol Psychiatry; 1996 Jan; 39(1):1-4. PubMed ID: 8719118 [No Abstract] [Full Text] [Related]
14. [Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome: a case report]. Terlikowska M; Marzański M Psychiatr Pol; 1995; 29(3):343-8. PubMed ID: 7652087 [TBL] [Abstract][Full Text] [Related]